Related Experiment Video
Updated: Apr 20, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Structural basis of AMPK regulation by adenine nucleotides and glycogen
Xiaodan Li1, Lili Wang1, X Edward Zhou2
11] Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong 510530, China [2] School of Life Science, University of Science and Technology of China, Hefei, Anhui 230027, China [3] Laboratory of Structural Sciences, Van Andel Research Institute, 333 Bostwick Ave, NE, Grand Rapids, MI 49503, USA.
Abstract:
AMP-activated protein kinase (AMPK) is a central cellular energy sensor and regulator of energy homeostasis, and a promising drug target for the treatment of diabetes, obesity, and cancer. Here we present low-resolution crystal structures of the human α1β2γ1 holo-AMPK complex bound to its allosteric modulators AMP and the glycogen-mimic cyclodextrin, both in the phosphorylated (4.05 Å) and non-phosphorylated (4.60 Å) state. In addition, we have solved a 2.95 Å structure of the human kinase domain (KD) bound to the adjacent autoinhibitory domain (AID) and have performed extensive biochemical and mutational studies. Together, these studies illustrate an underlying mechanism of allosteric AMPK modulation by AMP and glycogen, whose binding changes the equilibria between alternate AID (AMP) and carbohydrate-binding module (glycogen) interactions.
Insights
AMP-activated protein kinase (AMPK), a key energy regulator and drug target, is modulated by AMP and glycogen. Structural and biochemical studies reveal how these molecules alter AMPK
Area of Science:
- Biochemistry and Structural Biology
- Molecular Medicine
- Metabolic Regulation
Background:
- AMP-activated protein kinase (AMPK) is a critical cellular energy sensor.
- AMPK plays a vital role in maintaining energy homeostasis.
- AMPK is a significant therapeutic target for metabolic diseases like diabetes and obesity, as well as cancer.
Purpose of the Study:
- To elucidate the structural basis of allosteric modulation of human AMPK by AMP and glycogen.
- To understand the mechanism by which AMP and glycogen binding affects AMPK activity.
- To provide insights into AMPK regulation for potential therapeutic interventions.
Main Methods:
- Low-resolution crystal structures of the human α1β2γ1 holo-AMPK complex were determined (4.05 Å and 4.60 Å).
- A high-resolution (2.95 Å) crystal structure of the human kinase domain (KD) with the autoinhibitory domain (AID) was solved.
- Extensive biochemical and mutational studies were conducted to validate structural findings.
Main Results:
- Crystal structures reveal the holo-AMPK complex bound to allosteric modulators AMP and cyclodextrin (glycogen mimic).
- Structures were obtained for both phosphorylated and non-phosphorylated states of AMPK.
- The study illustrates how AMP and glycogen binding shifts the equilibrium between different interactions involving the AID and carbohydrate-binding module.
Conclusions:
- AMP and glycogen act as allosteric modulators of AMPK through distinct binding interactions.
- These interactions influence the conformational state and activity of AMPK.
- The findings provide a mechanistic understanding of AMPK regulation by key metabolic signals.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Global Regulatory Systems
Amplifying Signals via Enzymatic Cascade
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

